We are delighted to announce that we are traveling back to Boston on May 2-6. For the first time in over 2 years, more than 100 exhibitors will be returning to PEGS Boston, and finally, we all meet face to face again.
We are also proud to announce that we will present our newest addition to the iLite® Portfolio with Assay Ready Cells of ADCP Effector cells, CD3 Effector cells and CD19 Target cells.
Meet us there and listen to these latest innovations and improvements and learn from our long experience in assay development, bioanalysis, and clinical diagnostics which makes us an ideal partner for pharma, biotech, and CROs.